UBS Group’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ACHC
KCM
VPM
DM
DCM
ABI
VCM
UBS Group's ACHC Position: Q1 2026 in Review
UBS Group increased its Acadia Healthcare (ACHC) stake by 43% in Q1 2026, buying an estimated $15.5M and bringing the position to 2,833,862 shares worth $66.3M. The position accounts for 0.01% of the portfolio, ranked #1364.
UBS Group first reported a position in ACHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $107M in Q3 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.
- UBS Group held 2,833,862 shares of Acadia Healthcare worth $66.3M as of Q1 2026.
- UBS Group bought 855,771 Acadia Healthcare shares in Q1 2026, an estimated $15.5M.
- Acadia Healthcare made up 0.01% of UBS Group's portfolio in Q1 2026, its #1364 holding.
- UBS Group first reported a position in Acadia Healthcare in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Acadia Healthcare position peaked at $107M in Q3 2025.
- 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.